149 related articles for article (PubMed ID: 19422058)
41. Extended substrate specificity of opossum chymase--implications for the origin of mast cell chymases.
Reimer JM; Enoksson M; Samollow PB; Hellman L
Mol Immunol; 2008 Apr; 45(7):2116-25. PubMed ID: 18022236
[TBL] [Abstract][Full Text] [Related]
42. Engineered resistance against proteinases.
Milner M; Chroboczek J; Zagorski-Ostoja W
Acta Biochim Pol; 2007; 54(3):523-36. PubMed ID: 17823663
[TBL] [Abstract][Full Text] [Related]
43. Crystal structure of the anticarcinogenic Bowman-Birk inhibitor from snail medic (Medicago scutellata) seeds complexed with bovine trypsin.
Capaldi S; Perduca M; Faggion B; Carrizo ME; Tava A; Ragona L; Monaco HL
J Struct Biol; 2007 Apr; 158(1):71-9. PubMed ID: 17142058
[TBL] [Abstract][Full Text] [Related]
44. SPINKL, a Kazal-type serine protease inhibitor-like protein purified from mouse seminal vesicle fluid, is able to inhibit sperm capacitation.
Lin MH; Lee RK; Hwu YM; Lu CH; Chu SL; Chen YJ; Chang WC; Li SH
Reproduction; 2008 Nov; 136(5):559-71. PubMed ID: 18715980
[TBL] [Abstract][Full Text] [Related]
45. Distinction of sperm-binding site and reactive site for trypsin inhibition on p12 secreted from the accessory sex glands of male mice.
Luo CW; Lin HJ; Gopinath SC; Chen YH
Biol Reprod; 2004 Apr; 70(4):965-71. PubMed ID: 14645103
[TBL] [Abstract][Full Text] [Related]
46. Helicobacter pylori UreE, a urease accessory protein: specific Ni(2+)- and Zn(2+)-binding properties and interaction with its cognate UreG.
Bellucci M; Zambelli B; Musiani F; Turano P; Ciurli S
Biochem J; 2009 Jul; 422(1):91-100. PubMed ID: 19476442
[TBL] [Abstract][Full Text] [Related]
47. Introduction of non-natural amino acid residues into the substrate-specific P1 position of trypsin inhibitor SFTI-1 yields potent chymotrypsin and cathepsin G inhibitors.
Łegowska A; Debowski D; Lesner A; Wysocka M; Rolka K
Bioorg Med Chem; 2009 May; 17(9):3302-7. PubMed ID: 19362846
[TBL] [Abstract][Full Text] [Related]
48. Amino acid sequence elucidation of human acrosin-trypsin inhibitor (HUSI-II) reveals that Kazal-type proteinase inhibitors are structurally related to beta-subunits of glycoprotein hormones.
Fink E; Hehlein-Fink C; Eulitz M
FEBS Lett; 1990 Sep; 270(1-2):222-4. PubMed ID: 2226783
[TBL] [Abstract][Full Text] [Related]
49. Inhibitory plant serpins with a sequence of three glutamine residues in the reactive center.
Hejgaard J
Biol Chem; 2005 Dec; 386(12):1319-23. PubMed ID: 16336127
[TBL] [Abstract][Full Text] [Related]
50. Recombinant human serine racemase: enzymologic characterization and comparison with its mouse ortholog.
Hoffman HE; Jirásková J; Ingr M; Zvelebil M; Konvalinka J
Protein Expr Purif; 2009 Jan; 63(1):62-7. PubMed ID: 18812225
[TBL] [Abstract][Full Text] [Related]
51. Catalytic mechanism of SHCHC synthase in the menaquinone biosynthesis of Escherichia coli: identification and mutational analysis of the active site residues.
Jiang M; Chen X; Wu XH; Chen M; Wu YD; Guo Z
Biochemistry; 2009 Jul; 48(29):6921-31. PubMed ID: 19545176
[TBL] [Abstract][Full Text] [Related]
52. VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active form.
Jankun J; Aleem AM; Selman SH; Basrur V; Skrzypczak-Jankun E
Int J Mol Med; 2009 Jan; 23(1):57-63. PubMed ID: 19082507
[TBL] [Abstract][Full Text] [Related]
53. Structure-function roles of four cysteine residues in the human arsenic (+3 oxidation state) methyltransferase (hAS3MT) by site-directed mutagenesis.
Song X; Geng Z; Zhu J; Li C; Hu X; Bian N; Zhang X; Wang Z
Chem Biol Interact; 2009 May; 179(2-3):321-8. PubMed ID: 19167370
[TBL] [Abstract][Full Text] [Related]
54. Differential NKG2D binding to highly related human NKG2D ligands ULBP2 and RAET1G is determined by a single amino acid in the alpha2 domain.
Wittenbrink M; Spreu J; Steinle A
Eur J Immunol; 2009 Jun; 39(6):1642-51. PubMed ID: 19424970
[TBL] [Abstract][Full Text] [Related]
55. Identification and characterization of a Bowman-Birk inhibitor active towards trypsin but not chymotrypsin in Lupinus albus seeds.
Scarafoni A; Consonni A; Galbusera V; Negri A; Tedeschi G; Rasmussen P; Magni C; Duranti M
Phytochemistry; 2008 Jun; 69(9):1820-5. PubMed ID: 18474386
[TBL] [Abstract][Full Text] [Related]
56. Upregulation of SPINK2 in acute myeloid leukemia.
Gezer S; Emrence Z; Elverdi T; Ar MC; Salman Yaylaz B; Paçal F; Ünüvar A; Sarıman M; Eşkazan AE; Karaman S; Salihoğlu A; Karakaş Z; Abacı N; Sırma-Ekmekci S
Adv Lab Med; 2023 Apr; 4(1):92-104. PubMed ID: 37359898
[TBL] [Abstract][Full Text] [Related]
57. A protein scaffold, engineered SPINK2, for generation of inhibitors with high affinity and specificity against target proteases.
Nishimiya D; Kawaguchi Y; Kodama S; Nasu H; Yano H; Yamaguchi A; Tamura M; Hashimoto R
Sci Rep; 2019 Aug; 9(1):11436. PubMed ID: 31391482
[TBL] [Abstract][Full Text] [Related]
58. Analysis of the stability and function of nucleoplasmin through cysteine mutants.
Arnan C; Prieto C; Chiva M; Salvany L; Ausió J; Subirana JA; Saperas N
Arch Biochem Biophys; 2005 May; 437(2):205-14. PubMed ID: 15850560
[TBL] [Abstract][Full Text] [Related]
59. Mapping and identification of the region and secondary structure required for the maturation of the nukacin ISK-1 prepeptide.
Nagao J; Morinaga Y; Islam MR; Asaduzzaman SM; Aso Y; Nakayama J; Sonomoto K
Peptides; 2009 Aug; 30(8):1412-20. PubMed ID: 19481127
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and application of MeOSuc-Ala-Ala-Pro-Phe-CH2Cl as potent proteinase K inhibitor.
Kore AR; Shanmugasundaram M; Hoang Q; Kuo M; Chapman LM; Chen HH
Bioorg Med Chem Lett; 2009 Mar; 19(5):1296-300. PubMed ID: 19211247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
